{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:31:28Z","timestamp":1790069488569,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Major Scientific and Technological Special Project","award":["2014ZX09507003-003"],"award-info":[{"award-number":["2014ZX09507003-003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402943"],"award-info":[{"award-number":["81402943"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PUMC Youth Fund","award":["33320140046"],"award-info":[{"award-number":["33320140046"]}]},{"name":"PUMC Youth Fund","award":["3332015168"],"award-info":[{"award-number":["3332015168"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00210-017-1345-8","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:58:42Z","timestamp":1485385122000},"page":"423-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-\u03baB and activating SIRT1"],"prefix":"10.1007","volume":"390","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-chang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-ying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"1345_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jcp.21290","volume":"215","author":"R Alessandro","year":"2008","unstructured":"Alessandro R et al (2008) Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia. J Cell Physiol 215:111\u2013121. doi: 10.1002\/jcp.21290","journal-title":"J Cell Physiol"},{"key":"1345_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14:754\u2013762. doi: 10.1038\/nrc3829","journal-title":"Nat Rev Cancer"},{"key":"1345_CR3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.4161\/cbt.8.19.9593","volume":"8","author":"N Azad","year":"2009","unstructured":"Azad N et al (2009) A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors. Cancer Biology & Therapy 8:1800\u20131805","journal-title":"Cancer Biology & Therapy"},{"key":"1345_CR4","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.2337\/db13-0138","volume":"62","author":"E Bach","year":"2013","unstructured":"Bach E et al (2013) Direct effects of TNF-alpha on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release. Diabetes 62:4023\u20134029. doi: 10.2337\/db13-0138","journal-title":"Diabetes"},{"key":"1345_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13\u201320","journal-title":"Cell"},{"key":"1345_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)35258-9","volume":"292","author":"KS Bauer","year":"2000","unstructured":"Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD (2000) Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway. J Pharmacol Exp Ther 292:31\u201337","journal-title":"J Pharmacol Exp Ther"},{"key":"1345_CR7","doi-asserted-by":"publisher","unstructured":"Beane J, Cheng L, Soldi R, Zhang X, Liu G, Anderlind C, Lenburg ME, Spira A, Bild AH (2012) SIRT1 Pathway Dysregulation in the Smoke-Exposed Airway Epithelium and Lung Tumor Tissue. Cancer Res 72(22):5702\u20135711. doi: 10.1158\/0008-5472.CAN-12-1043","DOI":"10.1158\/0008-5472.CAN-12-1043"},{"key":"1345_CR8","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC et al (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704\u20131708. doi: 10.1126\/science.1065874","journal-title":"Science"},{"key":"1345_CR9","doi-asserted-by":"publisher","first-page":"19460","DOI":"10.1074\/jbc.M110.113092","volume":"285","author":"JJ Brault","year":"2010","unstructured":"Brault JJ, Jespersen JG, Goldberg AL (2010) Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy. J Biol Chem 285:19460\u201319471. doi: 10.1074\/jbc.M110.113092","journal-title":"J Biol Chem"},{"key":"1345_CR10","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011\u20132015. doi: 10.1126\/science.1094637","journal-title":"Science"},{"key":"1345_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrc3985","volume":"15","author":"A Chalkiadaki","year":"2015","unstructured":"Chalkiadaki A, Guarente L (2015) The multifaceted functions of sirtuins in cancer. Nat Rev Cancer 15:608\u2013624. doi: 10.1038\/nrc3985","journal-title":"Nat Rev Cancer"},{"key":"1345_CR12","doi-asserted-by":"publisher","first-page":"40364","DOI":"10.1074\/jbc.M509329200","volume":"280","author":"J Chen","year":"2005","unstructured":"Chen J et al (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280:40364\u201340374. doi: 10.1074\/jbc.M509329200","journal-title":"J Biol Chem"},{"key":"1345_CR13","doi-asserted-by":"publisher","unstructured":"Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, Smith SR, Ravussin E, Barzilai N (2007) Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans. PLoS Med 4(3):e76. doi: 10.1371\/journal.pmed.0040076","DOI":"10.1371\/journal.pmed.0040076"},{"key":"1345_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00280-004-0841-y","volume":"54","author":"AA Desai","year":"2004","unstructured":"Desai AA et al (2004) A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer. Cancer Chemother Pharmacol 54:377\u2013384. doi: 10.1007\/s00280-004-0841-y","journal-title":"Cancer Chemother Pharmacol"},{"key":"1345_CR15","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/cncr.21473","volume":"104","author":"JP Dutcher","year":"2005","unstructured":"Dutcher JP, Leon L, Manola J, Friedland DM, Roth B, Wilding G, Eastern Cooperative Oncology G (2005) Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative. Oncology Group Study Cancer 104:2392\u20132399. doi: 10.1002\/cncr.21473","journal-title":"Oncology Group Study Cancer"},{"key":"1345_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10:90\u201399. doi: 10.1038\/nrclinonc.2012.209","journal-title":"Nat Rev Clin Oncol"},{"key":"1345_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MCO.0b013e32833862df","volume":"13","author":"DJ Glass","year":"2010","unstructured":"Glass DJ (2010) Signaling pathways perturbing muscle mass. Current Opinion in Clinical Nutrition and Metabolic Care 13:225\u2013229","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"1345_CR18","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98:14440\u201314445. doi: 10.1073\/pnas.251541198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1345_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2014.10.018","volume":"746","author":"L Guo","year":"2015","unstructured":"Guo L et al (2015) Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases. Eur J Pharmacol 746:14\u201321. doi: 10.1016\/j.ejphar.2014.10.018","journal-title":"Eur J Pharmacol"},{"key":"1345_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1124\/jpet.107.131888","volume":"325","author":"L Guo","year":"2008","unstructured":"Guo L et al (2008) Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent. J Pharmacol Exp Ther 325:10\u201316. doi: 10.1124\/jpet.107.131888","journal-title":"J Pharmacol Exp Ther"},{"key":"1345_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1124\/jpet.112.192849","volume":"342","author":"L Guo","year":"2012","unstructured":"Guo L et al (2012) Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-kappaB activation, and colonic fibrosis. J Pharmacol Exp Ther 342:356\u2013365. doi: 10.1124\/jpet.112.192849","journal-title":"J Pharmacol Exp Ther"},{"key":"1345_CR22","doi-asserted-by":"publisher","first-page":"20015","DOI":"10.1074\/jbc.M802187200","volume":"283","author":"X Hou","year":"2008","unstructured":"Hou X et al (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283:20015\u201320026. doi: 10.1074\/jbc.M802187200","journal-title":"J Biol Chem"},{"key":"1345_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.01-0866com","volume":"16","author":"RB Hunter","year":"2002","unstructured":"Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC (2002) Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 16:529\u2013538","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"1345_CR24","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1200\/JCO.2003.04.136","volume":"21","author":"MM Hussain","year":"2003","unstructured":"Hussain MM et al (2003) Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21:4356\u20134363. doi: 10.1200\/JCO.2003.04.136","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"1345_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.lungcan.2007.10.003","volume":"60","author":"EA Johnson","year":"2008","unstructured":"Johnson EA et al (2008) Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 60:200\u2013207. doi: 10.1016\/j.lungcan.2007.10.003","journal-title":"Lung Cancer"},{"key":"1345_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","volume":"370","author":"R Ju","year":"2016","unstructured":"Ju R et al (2016) Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Cancer Lett 370:232\u2013241. doi: 10.1016\/j.canlet.2015.10.025","journal-title":"Cancer Lett"},{"key":"1345_CR27","first-page":"935","volume":"54","author":"EC Kohn","year":"1994","unstructured":"Kohn EC, Felder CC, Jacobs W, Holmes KA, Day A, Freer R, Liotta LA (1994) Structure-function analysis of signal and growth inhibition by carboxyamido-triazole. CAI Cancer Research 54:935\u2013942","journal-title":"CAI Cancer Research"},{"key":"1345_CR28","first-page":"1856","volume":"55","author":"EC Kohn","year":"1995","unstructured":"Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55:1856\u20131862","journal-title":"Cancer Res"},{"key":"1345_CR29","first-page":"1600","volume":"7","author":"EC Kohn","year":"2001","unstructured":"Kohn EC et al (2001) A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 7:1600\u20131609","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"1345_CR30","first-page":"3208","volume":"52","author":"EC Kohn","year":"1992","unstructured":"Kohn EC, Sandeen MA, Liotta LA (1992) In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52:3208\u20133212","journal-title":"Cancer Res"},{"key":"1345_CR31","doi-asserted-by":"publisher","unstructured":"Kwon H-S, Ott M (2008) The ups and downs of SIRT1. Trends Biochem Sci 33(11):517\u2013525. doi: 10.1016\/j.tibs.2008.08.001","DOI":"10.1016\/j.tibs.2008.08.001"},{"key":"1345_CR32","doi-asserted-by":"publisher","first-page":"30515","DOI":"10.1074\/jbc.M113.489716","volume":"288","author":"D Lee","year":"2013","unstructured":"Lee D, Goldberg AL (2013) SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem 288:30515\u201330526. doi: 10.1074\/jbc.M113.489716","journal-title":"J Biol Chem"},{"key":"1345_CR33","doi-asserted-by":"publisher","first-page":"30269","DOI":"10.1074\/jbc.M115.685164","volume":"290","author":"D Lee","year":"2015","unstructured":"Lee D, Goldberg AL (2015) Muscle wasting in fasting requires activation of NF-kappaB and inhibition of AKT\/mechanistic target of Rapamycin (mTOR) by the protein Acetylase, GCN5. J Biol Chem 290:30269\u201330279. doi: 10.1074\/jbc.M115.685164","journal-title":"J Biol Chem"},{"key":"1345_CR34","doi-asserted-by":"crossref","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","volume":"279","author":"YP Li","year":"2000","unstructured":"Li YP, Reid MB (2000) NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 279:R1165\u2013R1170","journal-title":"American Journal of Physiology Regulatory, Integrative and Comparative Physiology"},{"key":"1345_CR35","doi-asserted-by":"publisher","first-page":"9856","DOI":"10.1074\/jbc.M110.196790","volume":"286","author":"TF Liu","year":"2011","unstructured":"Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE (2011) NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem 286:9856\u20139864. doi: 10.1074\/jbc.M110.196790","journal-title":"J Biol Chem"},{"key":"1345_CR36","doi-asserted-by":"publisher","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408. doi: 10.1006\/meth.2001.1262","DOI":"10.1006\/meth.2001.1262"},{"key":"1345_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(98)00137-2","volume":"130","author":"M Llovera","year":"1998","unstructured":"Llovera M, Garcia-Martinez C, Lopez-Soriano J, Agell N, Lopez-Soriano FJ, Garcia I, Argiles JM (1998) Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Lett 130:19\u201327","journal-title":"Cancer Lett"},{"key":"1345_CR38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1009259521092","volume":"2","author":"KJ Luzzi","year":"1998","unstructured":"Luzzi KJ et al (1998) Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI). Angiogenesis 2:373\u2013379","journal-title":"Angiogenesis"},{"key":"1345_CR39","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/Jco.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539\u20131547. doi: 10.1200\/Jco.2012.45.2722","journal-title":"J Clin Oncol"},{"key":"1345_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10637-006-9023-6","volume":"25","author":"T Mikkelsen","year":"2007","unstructured":"Mikkelsen T, Lush R, Grossman SA, Carson KA, Fisher JD, Alavi JB, Rosenfeld S (2007) Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme. Investig New Drugs 25:259\u2013263. doi: 10.1007\/s10637-006-9023-6","journal-title":"Investig New Drugs"},{"key":"1345_CR41","first-page":"1239","volume":"30","author":"R Moore-Carrasco","year":"2007","unstructured":"Moore-Carrasco R, Busquets S, Almendro V, Palanki M, Lopez-Soriano FJ, Argiles JM (2007) The AP-1\/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia. Int J Oncol 30:1239\u20131245","journal-title":"Int J Oncol"},{"key":"1345_CR42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(04)00126-6","volume":"116","author":"MC Motta","year":"2004","unstructured":"Motta MC et al (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551\u2013563","journal-title":"Cell"},{"key":"1345_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1006\/bbrc.2001.4497","volume":"281","author":"CG Penner","year":"2001","unstructured":"Penner CG, Gang G, Wray C, Fischer JE, Hasselgren PO (2001) The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem Biophys Res Commun 281:1331\u20131336. doi: 10.1006\/bbrc.2001.4497","journal-title":"Biochem Biophys Res Commun"},{"key":"1345_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","volume":"3","author":"MJ Puppa","year":"2012","unstructured":"Puppa MJ, White JP, Velazquez KT, Baltgalvis KA, Sato S, Baynes JW, Carson JA (2012) The effect of exercise on IL-6-induced cachexia in the Apc ( Min\/+) mouse. J Cachex Sarcopenia Muscle 3:117\u2013137. doi: 10.1007\/s13539-011-0047-1","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"1345_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1096\/fj.11-189977","volume":"26","author":"SA Reed","year":"2012","unstructured":"Reed SA, Sandesara PB, Senf SM, Judge AR (2012) Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 26:987\u20131000. doi: 10.1096\/fj.11-189977","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"1345_CR46","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1073\/pnas.0607795103","volume":"103","author":"M Sandri","year":"2006","unstructured":"Sandri M et al (2006) PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A 103:16260\u201316265. doi: 10.1073\/pnas.0607795103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1345_CR47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri M et al (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399\u2013412","journal-title":"Cell"},{"key":"1345_CR48","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","volume":"280","author":"S Schiaffino","year":"2013","unstructured":"Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280:4294\u20134314. doi: 10.1111\/febs.12253","journal-title":"FEBS J"},{"key":"1345_CR49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P et al (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107\u20131112","journal-title":"J Natl Cancer Inst"},{"key":"1345_CR50","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369\u20132380. doi: 10.1038\/sj.emboj.7600244","journal-title":"EMBO J"},{"key":"1345_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","volume":"6","author":"J Zhao","year":"2007","unstructured":"Zhao J et al (2007) FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6:472\u2013483. doi: 10.1016\/j.cmet.2007.11.004","journal-title":"Cell Metab"},{"key":"1345_CR52","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1111\/bph.13138","volume":"172","author":"L Zhu","year":"2015","unstructured":"Zhu L et al (2015) Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis. Br J Pharmacol 172:3446\u20133459. doi: 10.1111\/bph.13138","journal-title":"Br J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1345-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1345-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:02:21Z","timestamp":1749931341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1345-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1345-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}